- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 21.08.24 | GSK's B7-H3-targeted ADC receives FDA breakthrough therapy status | ||
| 20.08.24 | FDA grants Fast Track Designation to Arthrosi Therapeutics's AR882 for gout treatment | ||
| 19.08.24 | EMA validates Type II Variation application for ENHERTU for breast cancer treatment | ||
| 16.08.24 | Aarvik announces ADC option exercise by collaboration partner ArriVent | ||
| 14.08.24 | FDA grants priority review for Bavarian Nordic's chikungunya vaccine BLA | ||
| 13.08.24 | Persist AI and Nivagen to develop AI-driven LAI manufacturing process | ||
| 12.08.24 | Sandoz's Enzeevu secures FDA approval for nAMD treatment | ||
| 09.08.24 | Bavarian Nordic secures $156.8m US vaccine deal | ||
| 08.08.24 | US FDA approves Purdue Pharma's Zurnai auto-injector | ||
| 07.08.24 | FDA accepts Exelixis' cabozantinib sNDA for neuroendocrine tumours | ||
| 06.08.24 | Santen and Cloudbreak enter licence agreement for pterygium treatment | ||
| 05.08.24 | Genmab assumes full ownership of acasunlimab | ||
| 02.08.24 | Health Canada grants approval for Celltrion's Steqeyma for multiple conditions | ||
| 01.08.24 | Jade Biosciences secures $80m to develop autoimmune therapies | ||
| 31.07.24 | Pinetree secures $17m to advance TPD development programmes | ||
| 30.07.24 | FDA approves Alpha Cognition's ZUNVEYL for Alzheimer's treatment | ||
| 29.07.24 | LEO Pharma obtains positive EMA CHMP opinion for eczema treatment | ||
| 26.07.24 | Confo Therapeutics secures €60m funds to progress GPCR-modulating therapies | ||
| 25.07.24 | Oisín secures funds to advance treatments for age-related ailments | ||
| 24.07.24 | FDA grants RMAT designation to AffyImmune's AIC100 for thyroid cancer | ||
| 23.07.24 | Vividion Therapeutics to expand capabilities with new R&D centre in US | ||
| 22.07.24 | Apollo Therapeutics and University of Oxford sign drug discovery partnership | ||
| 19.07.24 | Diamyd Medical secures FDA fast track status for type 1 diabetes treatment |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
